IL213476A0 - Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles - Google Patents

Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles

Info

Publication number
IL213476A0
IL213476A0 IL213476A IL21347611A IL213476A0 IL 213476 A0 IL213476 A0 IL 213476A0 IL 213476 A IL213476 A IL 213476A IL 21347611 A IL21347611 A IL 21347611A IL 213476 A0 IL213476 A0 IL 213476A0
Authority
IL
Israel
Prior art keywords
methods
multiple sclerosis
treating multiple
tetracyclic pyrazinoindoles
pyrazinoindoles
Prior art date
Application number
IL213476A
Other languages
English (en)
Original Assignee
Biovista Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biovista Inc filed Critical Biovista Inc
Publication of IL213476A0 publication Critical patent/IL213476A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IL213476A 2008-12-11 2011-06-12 Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles IL213476A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12157408P 2008-12-11 2008-12-11
US23323509P 2009-08-12 2009-08-12
PCT/US2009/067673 WO2010068867A1 (en) 2008-12-11 2009-12-11 Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles

Publications (1)

Publication Number Publication Date
IL213476A0 true IL213476A0 (en) 2011-07-31

Family

ID=42243090

Family Applications (1)

Application Number Title Priority Date Filing Date
IL213476A IL213476A0 (en) 2008-12-11 2011-06-12 Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles

Country Status (9)

Country Link
US (1) US20110268699A1 (enExample)
EP (1) EP2375900B1 (enExample)
JP (1) JP2012512165A (enExample)
CN (1) CN102395275A (enExample)
AU (1) AU2009324495B2 (enExample)
BR (1) BRPI0922871A2 (enExample)
CA (1) CA2747235C (enExample)
IL (1) IL213476A0 (enExample)
WO (1) WO2010068867A1 (enExample)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2340254B8 (en) 2008-09-15 2014-05-21 Biovista, Inc. Compositions and methods for treating epilepsy
JP5934102B2 (ja) 2009-10-30 2016-06-15 レトロトップ、 インコーポレイテッドＲｅｔｒｏｔｏｐｅ， Ｉｎｃ． Ｐｕｆａ誘導体による酸化ストレス障害の緩和
RU2436786C1 (ru) * 2010-07-23 2011-12-20 Александр Васильевич Иващенко Замещенные индолы, противовирусный активный компонент, способ получения и применения
CA2834342C (en) 2011-04-26 2021-08-31 Retrotope, Inc. Impaired energy processing disorders and mitochondrial deficiency
WO2012148926A2 (en) * 2011-04-26 2012-11-01 Retrotope, Inc. Neurodegenerative disorders and muscle diseases implicating pufas
KR102110175B1 (ko) 2011-04-26 2020-05-13 레트로토프 인코포레이티드 Ｐｕｆａ 산화와 관련된 장애
AU2012249921B2 (en) 2011-04-26 2017-06-08 Biojiva Llc Oxidative retinal diseases
WO2013130422A1 (en) * 2012-02-27 2013-09-06 Biovista, Inc. Compositions and methods for treating mitochondrial diseases
CA2900503A1 (en) * 2013-02-15 2014-08-21 Teva Pharmaceutical Industries Ltd. Treatment of multiple sclerosis with laquinimod
KR101521807B1 (ko) * 2014-01-20 2015-05-20 한국전자통신연구원 데이터 전송 제어 장치 및 그 방법
MX373227B (es) * 2014-05-09 2020-04-21 Tecnimede Sociedade Tecnico Medicinal S Sales farmacéuticamente aceptables de enantiómeros de pirlindol para utilizarse en medicina.
EP3380452B1 (en) 2015-11-23 2021-03-24 Retrotope, Inc. Site-specific isotopic labeling of 1, 4-diene systems
US12097292B2 (en) 2016-08-28 2024-09-24 Mapi Pharma Ltd. Process for preparing microparticles containing glatiramer acetate
SMT202500136T1 (it) 2016-08-31 2025-05-12 Mapi Pharma Ltd Sistemi a deposito comprendenti glatiramer acetato
US11167003B2 (en) 2017-03-26 2021-11-09 Mapi Pharma Ltd. Methods for suppressing or alleviating primary or secondary progressive multiple sclerosis (PPMS or SPMS) using sustained release glatiramer depot systems
EP3520803A1 (en) * 2018-01-31 2019-08-07 Zarodex Therapeutics Limited Novel uses
US11779910B2 (en) 2020-02-21 2023-10-10 Biojiva Llc Processes for isotopic modification of polyunsaturated fatty acids and derivatives thereof
US12109194B2 (en) 2021-02-05 2024-10-08 Biojiva Llc Synergistic combination therapy for treating ALS

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3959470A (en) * 1972-11-28 1976-05-25 Mikhail Davidovich Mashkovsky Psychotropic medicinal preparation
US5300645A (en) * 1993-04-14 1994-04-05 Eli Lilly And Company Tetrahydro-pyrido-indole
US5795909A (en) * 1996-05-22 1998-08-18 Neuromedica, Inc. DHA-pharmaceutical agent conjugates of taxanes
WO2004098638A1 (ja) * 2003-05-06 2004-11-18 Ono Pharmaceutical Co., Ltd. エフェクター細胞機能阻害剤
RU2281085C2 (ru) * 2004-05-25 2006-08-10 Закрытое акционерное общество "Мастерлек" Антидепрессивные лекарственные средства для парентерального применения на основе сульфонатных солей пирлиндола
EP1688161A1 (en) * 2004-11-02 2006-08-09 Switch Biotech Aktiengesellschaft Use of pirlindole for the treatment of diseases which are characterized by proliferation of t-lymphocytes and/or hyperproliferation of keratinocytes in particular atopic dermatitis and psoriasis
CA2617102A1 (en) * 2005-07-28 2007-02-08 Bristol-Myers Squibb Company Substituted tetrahydro-1h-pyrido[4,3,b]indoles as serotonin receptor agonists and antagonists
CA2688327A1 (en) * 2007-05-25 2008-12-04 Medivation Neurology, Inc. Methods and compositions for stimulating cells

Also Published As

Publication number Publication date
EP2375900A1 (en) 2011-10-19
AU2009324495B2 (en) 2015-12-24
WO2010068867A1 (en) 2010-06-17
AU2009324495A1 (en) 2011-07-28
CA2747235A1 (en) 2010-06-17
EP2375900B1 (en) 2016-03-02
EP2375900A4 (en) 2012-05-02
BRPI0922871A2 (pt) 2016-11-16
JP2012512165A (ja) 2012-05-31
CA2747235C (en) 2021-02-09
US20110268699A1 (en) 2011-11-03
CN102395275A (zh) 2012-03-28

Similar Documents

Publication Publication Date Title
IL266189A (en) Methods for treating advanced multiple sclerosis
IL213476A0 (en) Methods for treating multiple sclerosis using tetracyclic pyrazinoindoles
IL257418A (en) Methods for treating addiction
IL212348A0 (en) Treatment method
IL209895A0 (en) Compounds for treating beta-amyloidoses
PT2096102E (pt) Processo para a produção de metileno-difenil-diisocianatos
GB0808973D0 (en) Radiotherapy apparatus
GB0803107D0 (en) Method
IL208069A0 (en) Methods for treating psoriasis
GB0804981D0 (en) Method
GB0807409D0 (en) Method
GB0813599D0 (en) Method
GB0815428D0 (en) Method
GB0804690D0 (en) Method
GB0807410D0 (en) Method
GB0809404D0 (en) Method
ZA201101329B (en) Recarburisation method
GB0813494D0 (en) Method
GB0812559D0 (en) Method
GB0805862D0 (en) Method
EP2296461A4 (en) METHODS OF TREATING ARTHROPODS
GB0812102D0 (en) Method
GB0806186D0 (en) Method
GB0811166D0 (en) Method
GB0810116D0 (en) Method